MIXED HYPERLIPEMIA

Clinical trials for MIXED HYPERLIPEMIA explained in plain language.

Never miss a new study

Get alerted when new MIXED HYPERLIPEMIA trials appear

Sign up with your email to follow new studies for MIXED HYPERLIPEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

CRISPR One-Shot aims to fix stubborn cholesterol for good

Disease control Recruiting now

This is the first human trial of an experimental one-time treatment called CTX310, which uses CRISPR gene-editing technology. It aims to permanently lower harmful cholesterol and fat levels in the blood of adults whose levels don't respond well to existing medications. The study …

Matched conditions: MIXED HYPERLIPEMIA

Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

MIXED HYPERLIPEMIA

Get alerted when new MIXED HYPERLIPEMIA trials appear

CRISPR One-Shot aims to fix stubborn cholesterol for good